Cluster  	Cluster  	 NN	O
of  	of  	 IN	O
cardiometabolic  	cardiometabolic  	 JJ	B-NP
risk  	risk  	 NN	I-NP
factors  	factors  	 NNS	I-NP
in  	in  	 IN	O
children  	children  	 NNS	O
with  	with  	 IN	O
GH  	GH  	 NNP	B-NP
deficiency 	deficiency 	 NN	I-NP
:  	:  	 :	O
a  	a  	 DT	O
prospective 	prospective 	 JJ	O
,  	,  	 ,	O
case-control  	case-control  	 JJ	B-NP
study  	study  	 NN	I-NP
Growth  	Growth  	 NN	I-NP
hormone  	hormone  	 NN	I-NP
( 	( 	 -LRB-	O
GH 	GH 	 NNP	B-NP
)  	)  	 -RRB-	O
deficiency  	deficiency  	 NN	O
( 	( 	 -LRB-	O
GHD 	GHD 	 NNP	B-NP
)  	)  	 -RRB-	O
in  	in  	 IN	O
adults  	adults  	 NNS	O
is  	is  	 VBZ	O
associated  	associated  	 VBN	O
with  	with  	 IN	O
increased  	increased  	 JJ	O
cardiovascular  	cardiovascular  	 NNS	B-NP
( 	( 	 -LRB-	O
CV 	CV 	 NNP	B-NP
)  	)  	 -RRB-	O
risk 	risk 	 NN	O
.  	.  	 .	O
Although  	Although  	 IN	O
some  	some  	 DT	O
authors  	authors  	 NNS	O
have  	have  	 VBP	O
documented  	documented  	 VBN	O
the  	the  	 DT	O
presence  	presence  	 NN	O
of  	of  	 IN	O
early  	early  	 JJ	O
CV  	CV  	 NNP	O
risk  	risk  	 NN	B-NP
factors  	factors  	 NNS	I-NP
in  	in  	 IN	O
untreated  	untreated  	 JJ	O
GHD  	GHD  	 NN	B-NP
children 	children 	 NNS	I-NP
,  	,  	 ,	O
results  	results  	 NNS	O
are  	are  	 VBP	O
still  	still  	 RB	O
inconsistent 	inconsistent 	 JJ	O
.  	.  	 .	O
Aim  	Aim  	 NN	O
of  	of  	 IN	O
this  	this  	 DT	O
study  	study  	 NN	O
was  	was  	 VBD	O
to  	to  	 TO	O
evaluate  	evaluate  	 VB	O
the  	the  	 DT	O
effects  	effects  	 NNS	O
of  	of  	 IN	O
GHD  	GHD  	 NNP	B-NP
and  	and  	 CC	O
GH  	GH  	 NNP	B-NP
therapy  	therapy  	 NN	I-NP
on  	on  	 IN	O
early  	early  	 JJ	O
cardiometabolic  	cardiometabolic  	 JJ	B-NP
risk  	risk  	 NN	I-NP
factors  	factors  	 NNS	I-NP
in  	in  	 IN	O
a  	a  	 DT	O
large  	large  	 JJ	O
cohort  	cohort  	 NN	B-NP
of  	of  	 IN	O
children 	children 	 NNS	O
.  	.  	 .	O
Waist-to-height  	Waist-to-height  	 JJ	B-NP
ratio  	ratio  	 NN	I-NP
( 	( 	 -LRB-	O
WHtR 	WHtR 	 NNP	B-NP
) 	) 	 -RRB-	O
,  	,  	 ,	O
triglycerides 	triglycerides 	 NN	B-NP
,  	,  	 ,	O
total- 	total- 	 NNP	O
,  	,  	 ,	O
low-density  	low-density  	 NN	B-NP
lipoprotein  	lipoprotein  	 NNS	I-NP
( 	( 	 -LRB-	O
LDL 	LDL 	 NNP	B-NP
) 	) 	 -RRB-	O
,  	,  	 ,	O
high-density  	high-density  	 JJ	B-NP
lipoprotein  	lipoprotein  	 NNS	I-NP
( 	( 	 -LRB-	O
HDL 	HDL 	 NNP	B-NP
)  	)  	 -RRB-	O
cholesterol 	cholesterol 	 NN	B-NP
,  	,  	 ,	O
atherogenic  	atherogenic  	 JJ	B-NP
index  	index  	 NN	I-NP
( 	( 	 -LRB-	O
AI  	AI  	 NNP	B-NP
=  	=  	 SYM	O
total  	total  	 FW	O
/ 	/ 	 FW	O
HDL  	HDL  	 FW	O
cholesterol 	cholesterol 	 FW	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
homocysteine 	homocysteine 	 NN	B-NP
,  	,  	 ,	O
leptin 	leptin 	 NN	B-NP
,  	,  	 ,	O
adiponectin 	adiponectin 	 NN	B-NP
,  	,  	 ,	O
high-sensitivity  	high-sensitivity  	 JJ	B-NP
C-reactive  	C-reactive  	 JJ	I-NP
protein  	protein  	 NN	I-NP
( 	( 	 -LRB-	O
hsCRP 	hsCRP 	 NNP	B-NP
)  	)  	 -RRB-	O
and  	and  	 CC	O
fibrinogen  	fibrinogen  	 NNS	B-NP
were  	were  	 VBD	O
evaluated  	evaluated  	 VBN	O
in  	in  	 IN	O
seventy-one  	seventy-one  	 NNP	O
GHD  	GHD  	 NNP	B-NP
children  	children  	 NNS	I-NP
( 	( 	 -LRB-	O
9·8  	9·8  	 CD	O
±  	±  	 CD	O
3·6  	3·6  	 CD	O
years 	years 	 NNS	O
)  	)  	 -RRB-	O
before  	before  	 IN	O
and  	and  	 CC	O
after  	after  	 IN	O
2  	2  	 CD	O
years  	years  	 NNS	O
of  	of  	 IN	O
GH  	GH  	 NNP	B-NP
therapy 	therapy 	 NN	I-NP
.  	.  	 .	O
Seventy-one  	Seventy-one  	 JJ	O
healthy  	healthy  	 JJ	O
controls  	controls  	 NNS	O
comparable  	comparable  	 JJ	O
with  	with  	 IN	O
patients  	patients  	 NNS	O
for  	for  	 IN	O
age 	age 	 NN	O
,  	,  	 ,	O
sex  	sex  	 NN	O
and  	and  	 CC	O
body  	body  	 NN	B-NP
mass  	mass  	 NN	I-NP
index  	index  	 NN	I-NP
( 	( 	 -LRB-	O
BMI 	BMI 	 NNP	B-NP
)  	)  	 -RRB-	O
were  	were  	 VBD	O
enrolled 	enrolled 	 VBN	O
.  	.  	 .	O
Compared  	Compared  	 VBN	O
with  	with  	 IN	O
controls 	controls 	 NNS	O
,  	,  	 ,	O
GHD  	GHD  	 NNP	B-NP
children  	children  	 NNS	I-NP
at  	at  	 IN	O
study  	study  	 NN	B-NP
entry  	entry  	 NN	I-NP
had  	had  	 VBD	O
higher  	higher  	 JJR	O
WHtR  	WHtR  	 NNS	B-NP
( 	( 	 -LRB-	O
0·52  	0·52  	 FW	O
±  	±  	 FW	O
0·05  	0·05  	 FW	O
vs  	vs  	 FW	O
0·45  	0·45  	 FW	O
±  	±  	 FW	O
0·19 	0·19 	 FW	O
,  	,  	 ,	O
P  	P  	 NN	O
=  	=  	 SYM	O
0·004 	0·004 	 CD	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
triglycerides  	triglycerides  	 NNS	B-NP
( 	( 	 -LRB-	O
0·44  	0·44  	 FW	O
±  	±  	 FW	O
0·98  	0·98  	 FW	O
vs  	vs  	 FW	O
-0·03  	-0·03  	 FW	O
±  	±  	 FW	O
0·73  	0·73  	 FW	O
SDS 	SDS 	 NNP	B-NP
,  	,  	 ,	O
P  	P  	 NN	O
=  	=  	 SYM	O
0·012 	0·012 	 CD	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
total  	total  	 JJ	B-NP
cholesterol  	cholesterol  	 NN	I-NP
( 	( 	 -LRB-	O
0·28  	0·28  	 FW	O
±  	±  	 FW	O
1·08  	1·08  	 FW	O
vs  	vs  	 FW	O
-0·46  	-0·46  	 FW	O
±  	±  	 FW	O
0·98  	0·98  	 FW	O
SDS 	SDS 	 NNP	B-NP
,  	,  	 ,	O
P  	P  	 NNP	O
< 	< 	 SYM	O
0·001 	0·001 	 NNP	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
LDL  	LDL  	 NNP	B-NP
cholesterol  	cholesterol  	 NN	I-NP
( 	( 	 -LRB-	O
0·20  	0·20  	 FW	O
±  	±  	 FW	O
0·90  	0·90  	 FW	O
vs  	vs  	 FW	O
-0·39  	-0·39  	 FW	O
±  	±  	 FW	O
1·06  	1·06  	 FW	O
SDS 	SDS 	 NNP	B-NP
,  	,  	 ,	O
P  	P  	 NN	O
=  	=  	 SYM	O
0·007 	0·007 	 CD	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
AI  	AI  	 NNP	B-NP
( 	( 	 -LRB-	O
3·19  	3·19  	 FW	O
±  	±  	 FW	O
0·73  	0·73  	 FW	O
vs  	vs  	 FW	O
2·77  	2·77  	 FW	O
±  	±  	 FW	O
0·53 	0·53 	 FW	O
,  	,  	 ,	O
P  	P  	 NN	O
=  	=  	 SYM	O
0·001 	0·001 	 CD	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
homocysteine  	homocysteine  	 NNS	B-NP
( 	( 	 -LRB-	O
8·45  	8·45  	 FW	O
±  	±  	 FW	O
1·8  	1·8  	 FW	O
vs  	vs  	 FW	O
7·72  	7·72  	 FW	O
±  	±  	 FW	O
1·6  	1·6  	 FW	O
μm 	μm 	 FW	B-NP
,  	,  	 ,	O
P  	P  	 NN	O
=  	=  	 SYM	O
0·003 	0·003 	 CD	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
leptin  	leptin  	 NNS	B-NP
( 	( 	 -LRB-	O
8·03  	8·03  	 FW	O
±  	±  	 FW	O
4·2  	4·2  	 FW	O
vs  	vs  	 FW	O
5·09  	5·09  	 FW	O
±  	±  	 FW	O
1·9  	1·9  	 FW	O
ng 	ng 	 FW	B-NP
/ 	/ 	 FW	I-NP
ml 	ml 	 FW	I-NP
,  	,  	 ,	O
P  	P  	 NN	O
=  	=  	 SYM	O
0·001 	0·001 	 CD	O
)  	)  	 -RRB-	O
and  	and  	 CC	O
fibrinogen  	fibrinogen  	 NNS	B-NP
( 	( 	 -LRB-	O
292·6  	292·6  	 CD	O
±  	±  	 CD	O
33  	33  	 CD	O
vs  	vs  	 CD	O
268  	268  	 CD	O
±  	±  	 CD	O
31·4  	31·4  	 CD	O
mg 	mg 	 CD	B-NP
/ 	/ 	 CD	I-NP
dl 	dl 	 NN	I-NP
,  	,  	 ,	O
P  	P  	 NN	O
=  	=  	 SYM	O
0·011 	0·011 	 CD	O
) 	) 	 -RRB-	O
.  	.  	 .	O
No  	No  	 DT	O
differences  	differences  	 NNS	O
were  	were  	 VBD	O
found  	found  	 VBN	O
in  	in  	 IN	O
adiponectin  	adiponectin  	 NN	B-NP
or  	or  	 CC	O
hsCRP 	hsCRP 	 JJ	O
.  	.  	 .	O
GH  	GH  	 NNP	B-NP
therapy  	therapy  	 NN	I-NP
was  	was  	 VBD	O
associated  	associated  	 VBN	O
with  	with  	 IN	O
a  	a  	 DT	O
significant  	significant  	 JJ	O
reduction  	reduction  	 NN	O
in  	in  	 IN	O
WHtR  	WHtR  	 NNP	B-NP
( 	( 	 -LRB-	O
P  	P  	 NNP	O
< 	< 	 SYM	O
0·001 	0·001 	 NNP	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
total  	total  	 JJ	B-NP
cholesterol  	cholesterol  	 NN	I-NP
( 	( 	 -LRB-	O
P  	P  	 NNP	O
< 	< 	 SYM	O
0·001 	0·001 	 NNP	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
LDL  	LDL  	 NNP	B-NP
cholesterol  	cholesterol  	 NN	I-NP
( 	( 	 -LRB-	O
P  	P  	 NN	O
=  	=  	 SYM	O
0·002 	0·002 	 CD	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
homocysteine  	homocysteine  	 NNS	B-NP
( 	( 	 -LRB-	O
P  	P  	 NN	O
=  	=  	 SYM	O
0·044 	0·044 	 CD	O
)  	)  	 -RRB-	O
leptin  	leptin  	 NNS	B-NP
( 	( 	 -LRB-	O
P  	P  	 NN	O
=  	=  	 SYM	O
0·022 	0·022 	 CD	O
)  	)  	 -RRB-	O
and  	and  	 CC	O
fibrinogen  	fibrinogen  	 NNS	B-NP
( 	( 	 -LRB-	O
P  	P  	 NN	O
=  	=  	 SYM	O
0·001 	0·001 	 CD	O
) 	) 	 -RRB-	O
.  	.  	 .	O
Moreover 	Moreover 	 RB	O
,  	,  	 ,	O
GH  	GH  	 NNP	B-NP
therapy  	therapy  	 NN	I-NP
was  	was  	 VBD	O
associated  	associated  	 VBN	O
with  	with  	 IN	O
a  	a  	 DT	O
significant  	significant  	 JJ	O
increase  	increase  	 NN	O
in  	in  	 IN	O
adiponectin  	adiponectin  	 JJ	B-NP
levels  	levels  	 NNS	I-NP
( 	( 	 -LRB-	O
P  	P  	 NN	O
=  	=  	 SYM	O
0·001 	0·001 	 CD	O
) 	) 	 -RRB-	O
.  	.  	 .	O
Our  	Our  	 PRP$	O
data  	data  	 NNS	O
suggest  	suggest  	 VBP	O
that  	that  	 IN	O
children  	children  	 NNS	O
with  	with  	 IN	O
untreated  	untreated  	 JJ	O
GHD  	GHD  	 NNP	B-NP
exhibit  	exhibit  	 VBD	O
a  	a  	 DT	O
cluster  	cluster  	 NN	O
of  	of  	 IN	O
early  	early  	 JJ	O
cardiovascular  	cardiovascular  	 JJ	B-NP
risk  	risk  	 NN	I-NP
factors  	factors  	 NNS	I-NP
and  	and  	 CC	O
that  	that  	 IN	O
GH  	GH  	 NNP	B-NP
treatment  	treatment  	 NN	I-NP
exerts  	exerts  	 VBZ	O
beneficial  	beneficial  	 JJ	O
effects  	effects  	 NNS	O
on  	on  	 IN	O
these  	these  	 DT	O
abnormalities 	abnormalities 	 NN	O
.  	.  	 .	O
